HKEX Sector Rotation: Mobility, Biotech, and Consumer Staples Navigate Strategic Shifts in 2026Global Report·Jul 21 at 04:13 AM02643-4.45%01780-20.45%
Structural Shifts in Hong Kong's Peripheral Equities: Repricing Supply Chains and Safe HavensGlobal Report·Jul 17 at 04:12 AM039960.00%89618+1.56%
Simcere SANBEXIN added to China 2026 National Essential Medicines ListPUBT·Jul 9 at 07:01 AM02096-2.72%
Vall d'Hebron Hospital Completes Europe's First Single-Port Robotic Pediatric Nephroureterectomy Using China's Surgerii SystemCoinLive·Jul 5 at 04:26 PM600521+0.31%02096-2.72%
Simcere Pharmaceutical Group Limited (2096) Receives a Buy from UBSTip Ranks·Jun 29 at 05:15 AM02096-2.72%
Biren Amin Initiates Buy on Rademikibart Developer with Overweight Rating and DCF-Based $7 Price Target on Differentiated Asthma/COPD OpportunityTip Ranks·Jun 26 at 05:05 AMCNTB+1.95%02096-2.72%
Simcere and Stanford partner to develop IPF therapiesPharmaceutical Technology·Jun 15 at 04:00 AM02096-2.72%
Simcere Pharma Reveals Research Deal With Stanford Medicine To Develop Treatment For IPFrttnews·Jun 12 at 03:59 AM02096-2.72%
03:32 ETSimcere Pharmaceutical Enters into a Research Collaboration Agreement with Stanford Medicine to Develop Innovative Therapies for Patients with Idiopathic Pulmonary Fibrosisprnewswire·Jun 12 at 02:35 AM02096-2.72%
